- Patent Title: Vaccination with immuno-isolated cells producing an immunomodulator
-
Application No.: US15332375Application Date: 2016-10-24
-
Publication No.: US09861689B2Publication Date: 2018-01-09
- Inventor: Nicolas Mach
- Applicant: MaxiVAX SA
- Applicant Address: CH Geneva
- Assignee: MaxiVax SA
- Current Assignee: MaxiVax SA
- Current Assignee Address: CH Geneva
- Agency: Cooley LLP
- Agent Ivor R. Elrifi; Christina K. Stock
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K9/00 ; C12P21/00 ; A61K9/48

Abstract:
Provided herein are vaccine compositions containing at least one retrievable biocompatible macrocapsule containing immuno-isolated allogeneic cells that secrete an immunomodulator such as GM-CSF (granulocyte-macrophage colony stimulating factor) and an antigenic component such as autologous tumor cells or infectious agents. Also provided are kits and pharmaceutical compositions containing the vaccine compositions as well as methods of use thereof for therapeutic or preventative vaccination against tumors or infectious agents.
Public/Granted literature
- US20170095546A1 VACCINATION WITH IMMUNO-ISOLATED CELLS PRODUCING AN IMMUNOMODULATOR Public/Granted day:2017-04-06
Information query